Get the full picture
Sign in to uncover key details.
Ascidian Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
80 Guest St Fl 4, Boston, Massachusetts,...Website
www.ascidian-tx.comRevenue
$7.2 MillionIndustry
About Ascidian Therapeutics
Ascidian Therapeutics is pioneering a new class of RNA therapeutics by rewriting RNA to treat diseases at their genetic roots. Their innovative RNA exon editing platform allows for precise post-transcriptional editing, enabling the replacement of multiple contiguous exons to create functional proteins. The company aims to provide durable treatments without the risks associated with direct DNA editing, targeting diseases that current gene editing technologies cannot address. Ascidian Therapeutics primarily serves patients with genetic mutations and collaborates with other organizations to advance their therapeutic solutions.Explore more
Ascidian Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Ascidian Therapeutics Tech Stack
A closer look at the technologies used by Ascidian Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ascidian Therapeutics
Sign Up For FreeTo access detailed company insights
Ascidian Therapeutics is pioneering a new class of RNA therapeutics by rewriting RNA to treat diseases at their genetic roots. Their innovative RNA exon editing platform allows for precise post-transcriptional editing, enabling the replacement of multiple contiguous exons to create functional proteins. The company aims to provide durable treatments... Read More
